Paper1928065
C1q nephropathy: a pediatric clinicopathologic study.
Iskandar SS and 2 others. Am J Kidney Dis, 1991. Cited by 60 papers, by iCite.
Cite this record
ConductScience Library. C1q nephropathy: a pediatric clinicopathologic study. Papers, record 1928065. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1928065
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Complement C1q | Major topic |
| Kidney Diseases | Major topic |
| Adolescent | |
| Child | |
| Child, Preschool | |
| Complement C3 | |
| Female | |
| Fluorescent Antibody Technique | |
| Humans | |
| Immunoglobulins | |
| Kidney Glomerulus | |
| Male |
Source PubMed
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 60 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42930038 | Primary Mesangial Proliferative Glomerulonephritis: The Forgotten Glomerulopathy. | Antibodies (Basel) | 2026 | https://conductscience.org/library/papers/42930038 | PubMed |
| 40950996 | Hepatic tuberculosis induced by rituximab treatment for C1q nephropathy with minimal change disease: a case report. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/40950996 | PubMed |
| 39678627 | Immunofluorescence Use and Techniques in Glomerular Diseases: A Review. | Glomerular Dis | 2024 | https://conductscience.org/library/papers/39678627 | PubMed |
| 35711019 | A possible role of classical complement pathway activation in the pathogenesis of immunoglobulin G nephropathy: a case report. | CEN Case Rep | 2023 | https://conductscience.org/library/papers/35711019 | PubMed |
| 35283565 | C1q Nephropathy in Children with Nephrotic Syndrome: Treatment Strategies and Outcomes. | Indian J Nephrol | 2022 | https://conductscience.org/library/papers/35283565 | PubMed |
| 33634050 | Case Report: Complete Remission of C1q Nephropathy Treated With a Single Low-Dose Rituximab, a Reality or Coincidence? | Front Pediatr | 2020 | https://conductscience.org/library/papers/33634050 | PubMed |
| 31002691 | C1q nephropathy in adults is a form of focal segmental glomerulosclerosis in terms of clinical characteristics. | PLoS One | 2019 | https://conductscience.org/library/papers/31002691 | PubMed |
| 29625558 | Predominant but silent C1q deposits in mesangium on transplanted kidneys - long-term observational study. | BMC Nephrol | 2018 | https://conductscience.org/library/papers/29625558 | PubMed |
| 26640759 | C1q Nephropathy: The Unique Underrecognized Pathological Entity. | Anal Cell Pathol (Amst) | 2015 | https://conductscience.org/library/papers/26640759 | PubMed |
| 25984017 | C1q nephropathy: a true immune complex disease or an immunologic epiphenomenon? | NDT Plus | 2009 | https://conductscience.org/library/papers/25984017 | PubMed |
| 25340146 | C1q nephropathy- unity in diversity. | J Renal Inj Prev | 2013 | https://conductscience.org/library/papers/25340146 | PubMed |
| 24326785 | C1q nephropathy in children: clinical characteristics and outcome. | Pediatr Nephrol | 2014 | https://conductscience.org/library/papers/24326785 | PubMed |
| 24282787 | Diverse clinical and histology presentation in c1q nephropathy. | Nephrourol Mon | 2013 | https://conductscience.org/library/papers/24282787 | PubMed |
| 23852271 | Do C1q or IgM nephropathies predict disease severity in children with minimal change nephrotic syndrome? | Pediatr Nephrol | 2014 | https://conductscience.org/library/papers/23852271 | PubMed |
| 23087557 | Non-nephronal hematuria misdiagnosed as C1q nephropathy: Look before you leap. | Indian J Nephrol | 2012 | https://conductscience.org/library/papers/23087557 | PubMed |
| 21107633 | Resolution of clinical and pathologic features of C1q nephropathy after rituximab therapy. | Clin Exp Nephrol | 2011 | https://conductscience.org/library/papers/21107633 | PubMed |
| 20180137 | C1q nephropathy in the pediatric population: pathology and pathogenesis. | Pediatr Nephrol | 2010 | https://conductscience.org/library/papers/20180137 | PubMed |
| 20116156 | Is collapsing C1q nephropathy another MYH9-associated kidney disease? A case report. | Am J Kidney Dis | 2010 | https://conductscience.org/library/papers/20116156 | PubMed |
| 19669167 | C1q nephropathy in a child presenting with recurrent gross hematuria. | Pediatr Nephrol | 2010 | https://conductscience.org/library/papers/19669167 | PubMed |
| 19373520 | Current status and issues of C1q nephropathy. | Clin Exp Nephrol | 2009 | https://conductscience.org/library/papers/19373520 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| C1QA | 712 | PubTator's text mining | https://conductscience.org/library/genes/712 | NCBI Gene |
| C3 | 718 | PubTator's text mining | https://conductscience.org/library/genes/718 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1928065
GET https://conductscience.org/api/papers/v1/1928065/cited_by?page=2